1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL SULFATASES MARKET BY FUNCTIONS
5.1. Introduction
5.2. Hormone Regulation
5.3. Cellular Degradation
5.4. Pathogenesis
5.5. Others
6. GLOBAL SULFATASES MARKET BY APPLICATION
6.1. Introduction
6.2. Hormone-Dependent Cancers
6.3. Lysosomal Storage Disorders
6.4. Developmental Abnormalities
6.5. Bacterial Pathogenesis
6.6. Others
7. GLOBAL SULFATASES MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Others
8. GLOBAL SULFATASES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Italy
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Sigma Aldrich (Marck KgaA)
10.2. Kura Biotech
10.3. Integrated Micro-Chromatography Systems
10.4. ProSpec-Tany TechnoGene Ltd.
10.5. Bio-Techne Corporation
10.6. R&D Systems Inc.
10.7. Creative Enzymes.
10.8. Biosynth.
10.9. Enzo Biochem Inc
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations LIST OF FIGURESLIST OF TABLES